We are live on
!
Find out more
Fidelity International Portfolio holdings
AUM
$129B
1-Year Est. Return
30.83%
This Fund
S&P 500
This Quarter
Est. Return
+6.23%
1 Year Est. Return
+30.83%
3 Year Est. Return
+84.29%
5 Year Est. Return
+110%
10 Year Est. Return
+535.69%
AUM
$29B
AUM Growth
+$2.89B
(+11%)
Cap. Flow
+$1.6B
Cap. Flow
% of AUM
5.52%
Top 10 Holdings %
Top 10 Hldgs %
17.32%
Holding
533
New
67
Increased
191
Reduced
199
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$519M |
| 2 |
Pfizer
PFE
|
+$351M |
| 3 |
Eli Lilly
LLY
|
+$212M |
| 4 |
Devon Energy
DVN
|
+$189M |
| 5 |
Cognizant
CTSH
|
+$171M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$246M |
| 2 |
US Bancorp
USB
|
+$182M |
| 3 |
Comcast
CMCSA
|
+$118M |
| 4 |
AbbVie
ABBV
|
+$115M |
| 5 |
Coca-Cola Europacific Partners
CCEP
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.57% |
| 2 | Technology | 16.55% |
| 3 | Financials | 16.53% |
| 4 | Communication Services | 10.27% |
| 5 | Consumer Staples | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
SL Green Realty
SLG
$3.88B
| $21.4M | 0.07% |
185,557
+9,395
| +5% | +$1.04M |
|
|
IHS
252
DELISTED
IHS INC CL-A COM STK
IHS
| $21.3M | 0.07% |
187,136
+31,754
| +20% | +$3.94M |
|
|
BHI
253
DELISTED
Baker Hughes
BHI
| $21M | 0.07% |
375,000
-421,915
| -53% | -$23.8M |
|
254
Honeywell
HON
$77.1B
| $20.9M | 0.07% |
232,299
-6,754
| -3% | -$581K |
|
|
SFUN
255
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
| $20.6M | 0.07% |
55,658
-23,741
| -30% | -$10.5M |
|
|
CVSA
256
Covista Inc
CVSA
$3.94B
| $20.6M | 0.07% |
433,033
-13,045
| -3% | -$613K |
|
257
Occidental Petroleum
OXY
$57B
| $20.5M | 0.07% |
254,654
-700,647
| -73% | -$58.1M |
|
258
Martin Marietta Materials
MLM
$33.6B
| $20.5M | 0.07% |
185,493
-62,663
| -25% | -$7.41M |
|
259
Bio-Techne
TECH
$11.2B
| $20.3M | 0.07% |
876,864
+73,912
| +9% | +$1.69M |
|
|
AVOL
260
DELISTED
AVOLON HLDGS LTD SHS (CYM)
AVOL
| $20.2M | 0.07% |
+1,021,241
| New | +$19.3M |
|
|
SLXP
261
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $20M | 0.07% |
174,188
+43,061
| +33% | +$5.22M |
|
262
Stellantis
STLA
$16.5B
| $20M | 0.07% |
+2,637,637
| New | +$19.5M |
|
|
PACW
263
DELISTED
PacWest Bancorp
PACW
| $19.9M | 0.07% |
438,087
+81,313
| +23% | +$3.57M |
|
|
LOCK
264
DELISTED
LifeLock, Inc.
LOCK
| $19.9M | 0.07% |
1,074,348
+314,152
| +41% | +$5.18M |
|
265
FTI Consulting
FCN
$4.82B
| $19.7M | 0.07% |
+510,395
| New | +$19.4M |
|
266
Avery Dennison
AVY
$12.3B
| $19.6M | 0.07% |
+378,418
| New | +$18M |
|
267
CF Industries
CF
$19.2B
| $19.5M | 0.07% |
358,610
+37,185
| +12% | +$1.96M |
|
|
HUB.B
268
DELISTED
HUBBELL INC CL-B
HUB.B
| $19.5M | 0.07% |
182,530
+39,558
| +28% | +$4.32M |
|
269
Host Hotels & Resorts
HST
$16.8B
| $19.4M | 0.07% |
814,185
-267,273
| -25% | -$6.08M |
|
270
AT&T
T
$165B
| $19.3M | 0.07% |
760,913
-60,114
| -7% | -$1.56M |
|
271
TJX Companies
TJX
$170B
| $19.2M | 0.07% |
560,634
+67,098
| +14% | +$2.14M |
|
|
VR
272
DELISTED
Validus Hold Ltd
VR
| $19.1M | 0.07% |
459,230
-169
| -0% | -$6.83K |
|
|
ALXN
273
DELISTED
Alexion Pharmaceuticals
ALXN
| $19M | 0.07% |
102,840
+3,551
| +4% | +$658K |
|
274
Baxter International
BAX
$11.6B
| $18.9M | 0.07% |
475,501
+85,209
| +22% | +$3.32M |
|
|
ACC
275
DELISTED
American Campus Communities, Inc.
ACC
| $18.9M | 0.07% |
456,711
+110,228
| +32% | +$4.34M |
|
Similar funds
Fidelity International's Q4 2014 Portfolio in Review
As of Q4 2014, Fidelity International held 533 positions worth $29B, up 11% from $26.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Fidelity International deployed $1.6B of net new capital in Q4 2014, opening 67 new positions and adding to 191 existing holdings. Its largest new stake was UBS Group: 30,316,557 shares worth $521M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Amgen, an estimated $246M trimmed.
- Fidelity International's largest Q4 2014 buy was UBS Group: 30,316,557 shares worth $521M.
- Fidelity International added most to Pfizer in Q4 2014, an estimated $351M increase.
- Fidelity International's biggest Q4 2014 reduction was Amgen, cutting an estimated $246M.
- Fidelity International fully exited Coca-Cola Europacific Partners in Q4 2014, selling an estimated $102M.
- Fidelity International's ten largest holdings make up 17% of its $29B portfolio in Q4 2014.
- Fidelity International opened 67 new positions and closed 55 in Q4 2014.
- Fidelity International's portfolio value rose 11% quarter-over-quarter to $29B.
Based on Fidelity International's 13F filing for Q4 2014, filed 17 Feb 2015.